cyclin E Inhibitors
Items 11 to 20 of 21 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $242.00 $871.00 | 1 | |
Dinaciclib is a broad-spectrum CDK inhibitor, affecting multiple CDKs including CDK1 and CDK2, leading to cell cycle arrest. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $77.00 $315.00 $658.00 | 1 | |
Indirubin-3'-monoxime (CAS 160807-49-8) is a chemical compound known for its role as a cyclin E inhibitor, affecting cell cycle processes. It interacts with cyclin E, influencing cellular mechanisms. | ||||||
Indirubin-5-sulfonic acid sodium salt | sc-221755 sc-221755A | 1 mg 5 mg | $57.00 $324.00 | |||
Indirubin-5-sulfonic acid sodium salt exhibits a unique affinity for cyclin E, modulating its activity through specific hydrogen bonding and hydrophobic interactions. This compound influences the phosphorylation state of cyclin E, thereby affecting its interaction with cyclin-dependent kinases. Its distinct sulfonic acid group enhances solubility and reactivity, allowing for rapid engagement in cellular signaling pathways. The compound's kinetic behavior reveals a sophisticated mechanism of action, contributing to the regulation of cell cycle progression. | ||||||
Oxindole I | sc-222104 | 10 mg | $273.00 | 2 | ||
Oxindole I demonstrates a remarkable ability to interact with cyclin E, primarily through π-π stacking and van der Waals forces. This compound alters the conformational dynamics of cyclin E, influencing its stability and interaction with cyclin-dependent kinases. Its unique structural features facilitate selective binding, leading to modulation of downstream signaling pathways. The compound's reactivity profile showcases its potential to engage in complex biochemical networks, impacting cellular proliferation and differentiation. | ||||||
AT7519 | 844442-38-2 | sc-364416 sc-364416A sc-364416B sc-364416C | 5 mg 10 mg 100 mg 1 g | $207.00 $246.00 $1025.00 $3065.00 | 1 | |
AT7519 is a multi-CDK inhibitor, including CDK4 and CDK6, as well as other kinases. | ||||||
PNU 112455A hydrochloride | 21886-12-4 | sc-222182 sc-222182A | 1 mg 5 mg | $82.00 $106.00 | ||
PNU 112455A hydrochloride (CAS 21886-12-4) is a chemical compound known for its role as a cyclin E inhibitor. It has been studied for its impact on cell cycle regulation. | ||||||
Aurora Kinase/Cdk Inhibitor | 443797-96-4 | sc-203829 | 5 mg | $440.00 | ||
The chemical compound "Aurora Kinase/Cdk Inhibitor" (CAS 443797-96-4) functions as a cyclin E inhibitor, affecting cell cycle regulation. It modulates specific cellular processes by targeting relevant kinases. | ||||||
CR8, (S)-Isomer | 1084893-56-0 | sc-311307 | 5 mg | $201.00 | ||
CR8, (S)-Isomer (CAS 1084893-56-0) is a chemical compound known for its role as a potent inhibitor of cyclin E. It has shown the ability to modulate cellular processes through its interaction with cyclin E. | ||||||
P276-00 | 920113-03-7 | sc-477932 | 1 mg | $380.00 | ||
P276-00 is a novel CDK inhibitor that targets CDK1, CDK2, and CDKIt has shown anti-cancer activity in research studies. | ||||||
SU 9516 | 377090-84-1 | sc-222330 sc-222330A | 5 mg 25 mg | $122.00 $383.00 | 3 | |
SU9516 is a selective CDK2 inhibitor that interferes with the activity of cyclin E-CDK2 complexes, thus blocking cell cycle progression. It's been studied as a potential anti-cancer agent. | ||||||